{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T10:48:35Z","timestamp":1759229315291},"reference-count":22,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2001,11,1]],"date-time":"2001-11-01T00:00:00Z","timestamp":1004572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2001,11]]},"DOI":"10.1054\/jocn.2001.0998","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T14:55:42Z","timestamp":1032447342000},"page":"557-561","source":"Crossref","is-referenced-by-count":15,"title":["Intrathecal application with liposome-entrapped Fasudil for cerebral vasospasm followingsubarachnoid hemorrhage in rats"],"prefix":"10.1054","volume":"8","author":[{"given":"Yoshihiro","family":"Takanashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuhiro","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshinari","family":"Meguro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc J.","family":"Kirchmeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa M.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John H.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1054\/jocn.2001.0998_RF1","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1212\/WNL.37.10.1586","article-title":"Predicting outcome ischemiaafter aneurysmal subarachnoid hemorrhage: influences of clinicalcondition, CT results and antifiblinolytic therapy: a report of theCooperative Aneurysm Study","volume":"37","author":"Adams","year":"1987","journal-title":"Neurology"},{"key":"10.1054\/jocn.2001.0998_RF2","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1097\/00003246-199506000-00004","article-title":"Medical complications ofaneurysmal subarachnoid hemorrhage: a report of multicenter,cooperative aneurysm study","volume":"23","author":"Solenski","year":"1995","journal-title":"Crit Care Med"},{"key":"10.1054\/jocn.2001.0998_RF3","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2176\/nmc.38.805","article-title":"Combination therapy of Fasudil hydrochloride and ozagrelsodium for cerebral vasospasm following aneurysmal subarachnoid hemorrhage","volume":"38","author":"Nakashima","year":"1998","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"10.1054\/jocn.2001.0998_RF4","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3171\/jns.1992.76.4.0571","article-title":"Effect of AT877 on cerebralvasospasm after aneurysmal subarachnoid hemorrhage","volume":"76","author":"Shibuya","year":"1992","journal-title":"J Neurosurg"},{"key":"10.1054\/jocn.2001.0998_RF5","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3171\/jns.1985.62.5.0721","article-title":"Evaluation of the efficacyof intrathecal nimodipine in canine models of chronic cerebral vasospasm","volume":"62","author":"Gioia","year":"1985","journal-title":"J. Neurosurg"},{"key":"10.1054\/jocn.2001.0998_RF6","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/BF01406653","article-title":"Reversal of cerebral arterial spasm by intrathecal administration of a calcium antagonist (nimodipine). An experimental study","volume":"70","author":"Voldby","year":"1984","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1054\/jocn.2001.0998_RF7","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3109\/08982109409037057","article-title":"Ammonium sulphate gradients for efficient and stable remote loading of amphipathic weak bases into liposomes and ligandosomes","volume":"4","author":"Bolotin","year":"1994","journal-title":"J Liposome Res"},{"key":"10.1054\/jocn.2001.0998_RF8","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0021-9258(18)70226-3","article-title":"Phosphorus assay in column chromatography","volume":"234","author":"Bartlett","year":"1959","journal-title":"J Biol Chem"},{"key":"10.1054\/jocn.2001.0998_RF9","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1161\/01.STR.16.4.595","article-title":"Subarachnoid haemorrhage in the rat: angiography and fluorescence microscopy of the major cerebral arteries","volume":"16","author":"Delgado","year":"1985","journal-title":"Stroke"},{"key":"10.1054\/jocn.2001.0998_RF10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1172\/JCI5357","article-title":"Heme oxygenase-1 induction as an intrinsic regulation against delayed cerebral vasospasm in rats","volume":"104","author":"Suzuki","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1054\/jocn.2001.0998_RF11","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0169-409X(95)00029-7","article-title":"Pharmacokinetics of longcirculating liposomes","volume":"16","author":"Allen","year":"1995","journal-title":"Adv Drug Del Rev"},{"key":"10.1054\/jocn.2001.0998_RF12","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0009-3084(86)90079-4","article-title":"Interactions of liposomes with serum proteins","volume":"40","author":"Bonte","year":"1986","journal-title":"Chem Phys Lipids"},{"key":"10.1054\/jocn.2001.0998_RF13","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v14.i2.10","article-title":"The role of immunoproteins in the survival ofliposomes in the circulation","volume":"14","author":"Devine","year":"1997","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"10.1054\/jocn.2001.0998_RF14","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0005-2736(91)90224-V","article-title":"The effect of blood serum on the size and stability of phospholipid liposomes","volume":"1065","author":"Jones","year":"1991","journal-title":"Biochim Biophys Acta"},{"key":"10.1054\/jocn.2001.0998_RF15","first-page":"1033","article-title":"Mechanism of action of a novelantivasospasm drug, HA1077","volume":"241","author":"Asano","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1054\/jocn.2001.0998_RF16","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/j.1476-5381.1989.tb12652.x","article-title":"Vasodilator actions of HA1077in vitro and in vivo putatively mediated by the inhibition of protein kinase","volume":"98","author":"Asano","year":"1989","journal-title":"Br J Pharmacol"},{"key":"10.1054\/jocn.2001.0998_RF17","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.1021\/bi00316a032","article-title":"Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C","volume":"23","author":"Hidaka","year":"1984","journal-title":"Biochemistry"},{"key":"10.1054\/jocn.2001.0998_RF18","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0014-2999(91)90545-2","article-title":"Effects of HA 1077, a protein kinase inhibitor, on myosin phosphorylation and tension in smooth muscle","volume":"195","author":"Seto","year":"1991","journal-title":"Eur J Pharmacol"},{"key":"10.1054\/jocn.2001.0998_RF19","first-page":"243","article-title":"Possible prophylactic potential of HA 1077, a Ca2+antagonist and vasodilator, on chronic cerebral vasospasm","volume":"220","author":"Satoh","year":"1992","journal-title":"Eur J Pharmacol"},{"key":"10.1054\/jocn.2001.0998_RF20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF01420194","article-title":"Effect of HA 1077, a novel calcium antagonistic spasmolytic agent on intracerebral arterioles of rats","volume":"103","author":"Takayasu","year":"1990","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1054\/jocn.2001.0998_RF21","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0014-2999(91)90008-E","article-title":"HA 1077 a novel calcium antagonistic antivasospasm drug, increases both cerebral blood flow and glucose metabolism in conscious rats","volume":"209","author":"Sako","year":"1991","journal-title":"Eur. J Pharmacol"},{"key":"10.1054\/jocn.2001.0998_RF22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF01541267","article-title":"The effect of intracellular calcium antagonist HA 1077 on delayed cerebral vasospasm in dogs","volume":"90","author":"Shibuya","year":"1988","journal-title":"Acta Neurochir (Wien)"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586801909981?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586801909981?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,16]],"date-time":"2021-05-16T06:52:53Z","timestamp":1621147973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586801909981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,11]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2001,11]]}},"alternative-id":["S0967586801909981"],"URL":"https:\/\/doi.org\/10.1054\/jocn.2001.0998","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2001,11]]}}}